» Articles » PMID: 23554530

Mitigating the Risk of HIV Infection with Opioid Substitution Treatment

Overview
Specialty Public Health
Date 2013 Apr 5
PMID 23554530
Citations 24
Authors
Affiliations
Soon will be listed here.
Citing Articles

The burden of skin and soft tissue, bone and joint infections in an Australian cohort of people who inject drugs.

Morgan B, Lancaster R, Boyagoda B, Ananda R, Attwood L, Jacka D BMC Infect Dis. 2024; 24(1):299.

PMID: 38454356 PMC: 10918955. DOI: 10.1186/s12879-024-09143-0.


The opioid receptor: emergence through millennia of pharmaceutical sciences.

Fairbanks C, Peterson C Front Pain Res (Lausanne). 2023; 4:960389.

PMID: 38028425 PMC: 10646403. DOI: 10.3389/fpain.2023.960389.


Should I Stay or Should I Go? A Qualitative Exploration of Stigma and Other Factors Influencing Opioid Agonist Treatment Journeys.

Carlisle V, Maynard O, Bagnall D, Hickman M, Shorrock J, Thomas K Int J Environ Res Public Health. 2023; 20(2).

PMID: 36674280 PMC: 9865602. DOI: 10.3390/ijerph20021526.


Opioid agonist treatment for people who are dependent on pharmaceutical opioids.

Nielsen S, Tse W, Larance B Cochrane Database Syst Rev. 2022; 9:CD011117.

PMID: 36063082 PMC: 9443668. DOI: 10.1002/14651858.CD011117.pub3.


Six-month buprenorphine-naloxone treatment is associated with neurocognitive function improvement in opioid dependence.

Ghosh A, Mahintamani T, Rana D, Basu D, Mattoo S Indian J Psychiatry. 2022; 64(2):199-208.

PMID: 35494328 PMC: 9045353. DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_792_21.


References
1.
Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hickman M . Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet. 2010; 376(9737):285-301. DOI: 10.1016/S0140-6736(10)60742-8. View

2.
Des Jarlais D, Arasteh K, McKnight C, Hagan H, Perlman D, Semaan S . Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV. Am J Public Health. 2011; 101(7):1277-83. PMC: 3110210. DOI: 10.2105/AJPH.2011.300130. View

3.
Hagan H, Pouget E, Des Jarlais D . A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. J Infect Dis. 2011; 204(1):74-83. PMC: 3105033. DOI: 10.1093/infdis/jir196. View

4.
Batki S, Gruber V, Bradley J, Bradley M, Delucchi K . A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users. Drug Alcohol Depend. 2002; 66(3):283-93. DOI: 10.1016/s0376-8716(01)00208-3. View

5.
Mathers B, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick R . HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010; 375(9719):1014-28. DOI: 10.1016/S0140-6736(10)60232-2. View